Cargando…
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4(BS)) of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein (Env). Unlike mature antibodies, corresponding VRC01 germline precursors poorly bind to Env. Immunogen design has mostly relied on glycan removal fr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237438/ https://www.ncbi.nlm.nih.gov/pubmed/30403372 http://dx.doi.org/10.7554/eLife.37688 |
_version_ | 1783371194077020160 |
---|---|
author | Borst, Andrew J Weidle, Connor E Gray, Matthew D Frenz, Brandon Snijder, Joost Joyce, M Gordon Georgiev, Ivelin S Stewart-Jones, Guillaume BE Kwong, Peter D McGuire, Andrew T DiMaio, Frank Stamatatos, Leonidas Pancera, Marie Veesler, David |
author_facet | Borst, Andrew J Weidle, Connor E Gray, Matthew D Frenz, Brandon Snijder, Joost Joyce, M Gordon Georgiev, Ivelin S Stewart-Jones, Guillaume BE Kwong, Peter D McGuire, Andrew T DiMaio, Frank Stamatatos, Leonidas Pancera, Marie Veesler, David |
author_sort | Borst, Andrew J |
collection | PubMed |
description | VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4(BS)) of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein (Env). Unlike mature antibodies, corresponding VRC01 germline precursors poorly bind to Env. Immunogen design has mostly relied on glycan removal from trimeric Env constructs and has had limited success in eliciting mature VRC01 bnAbs. To better understand elicitation of such bnAbs, we characterized the inferred germline precursor of VRC01 in complex with a modified trimeric 426c Env by cryo-electron microscopy and a 426c gp120 core by X-ray crystallography, biolayer interferometry, immunoprecipitation, and glycoproteomics. Our results show VRC01 germline antibodies interacted with a wild-type 426c core lacking variable loops 1–3 in the presence and absence of a glycan at position Asn276, with the latter form binding with higher affinity than the former. Interactions in the presence of an Asn276 oligosaccharide could be enhanced upon carbohydrate shortening, which should be considered for immunogen design. |
format | Online Article Text |
id | pubmed-6237438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-62374382018-11-19 Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core Borst, Andrew J Weidle, Connor E Gray, Matthew D Frenz, Brandon Snijder, Joost Joyce, M Gordon Georgiev, Ivelin S Stewart-Jones, Guillaume BE Kwong, Peter D McGuire, Andrew T DiMaio, Frank Stamatatos, Leonidas Pancera, Marie Veesler, David eLife Structural Biology and Molecular Biophysics VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4(BS)) of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein (Env). Unlike mature antibodies, corresponding VRC01 germline precursors poorly bind to Env. Immunogen design has mostly relied on glycan removal from trimeric Env constructs and has had limited success in eliciting mature VRC01 bnAbs. To better understand elicitation of such bnAbs, we characterized the inferred germline precursor of VRC01 in complex with a modified trimeric 426c Env by cryo-electron microscopy and a 426c gp120 core by X-ray crystallography, biolayer interferometry, immunoprecipitation, and glycoproteomics. Our results show VRC01 germline antibodies interacted with a wild-type 426c core lacking variable loops 1–3 in the presence and absence of a glycan at position Asn276, with the latter form binding with higher affinity than the former. Interactions in the presence of an Asn276 oligosaccharide could be enhanced upon carbohydrate shortening, which should be considered for immunogen design. eLife Sciences Publications, Ltd 2018-11-07 /pmc/articles/PMC6237438/ /pubmed/30403372 http://dx.doi.org/10.7554/eLife.37688 Text en http://creativecommons.org/publicdomain/zero/1.0/ http://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (http://creativecommons.org/publicdomain/zero/1.0/) . |
spellingShingle | Structural Biology and Molecular Biophysics Borst, Andrew J Weidle, Connor E Gray, Matthew D Frenz, Brandon Snijder, Joost Joyce, M Gordon Georgiev, Ivelin S Stewart-Jones, Guillaume BE Kwong, Peter D McGuire, Andrew T DiMaio, Frank Stamatatos, Leonidas Pancera, Marie Veesler, David Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title_full | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title_fullStr | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title_full_unstemmed | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title_short | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core |
title_sort | germline vrc01 antibody recognition of a modified clade c hiv-1 envelope trimer and a glycosylated hiv-1 gp120 core |
topic | Structural Biology and Molecular Biophysics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237438/ https://www.ncbi.nlm.nih.gov/pubmed/30403372 http://dx.doi.org/10.7554/eLife.37688 |
work_keys_str_mv | AT borstandrewj germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT weidleconnore germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT graymatthewd germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT frenzbrandon germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT snijderjoost germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT joycemgordon germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT georgievivelins germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT stewartjonesguillaumebe germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT kwongpeterd germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT mcguireandrewt germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT dimaiofrank germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT stamatatosleonidas germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT panceramarie germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core AT veeslerdavid germlinevrc01antibodyrecognitionofamodifiedcladechiv1envelopetrimerandaglycosylatedhiv1gp120core |